Reports for EMTRICITABINE

Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-04-03 2019-04-23 80423
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-04-23 2019-06-26 82201
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-07-03 2019-07-10 88291
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-07-29 2019-09-26 90113
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 200MG 300MG TABLET Resolved 2022-01-26 2022-02-04 153490
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 300MG 200MG TABLET Resolved 2022-08-15 2022-10-24 166805
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2021-04-12 2021-06-03 137370
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-09-15 2023-11-13 204524

Showing 21 to 28 of 28

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1